Dalibor Valík
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5
- Co-authors
- Jaroslav Štěrba (26 shared papers)Bořivoj Vojtěšek (13 shared papers)Lenka Zdražilová Dubská (29 shared papers)Regina Demlová (18 shared papers)Michael A. Sheard (2 shared papers)Viera Bajčiová (7 shared papers)Rudolf Nenutil (11 shared papers)Rostislav Vyzula (7 shared papers)
- Journals
- Annals of Oncology (4 papers)Oncology (3 papers)Frontiers in Oncology (3 papers)Physiological Research (2 papers)The International Journal of Biological Markers (2 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Dalibor Valík
68 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 212
- Genetics 119
- Oncology 300
- Immunology 155
- Molecular Biology 474
Countries citing papers authored by Dalibor Valík
This map shows the geographic impact of Dalibor Valík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalibor Valík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalibor Valík more than expected).
Fields of papers citing papers by Dalibor Valík
This network shows the impact of papers produced by Dalibor Valík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalibor Valík. The network helps show where Dalibor Valík may publish in the future.
Co-authors
The 25 scholars most cited alongside Dalibor Valík, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 110 | |
| 2 | 2008 | 85 | |
| 3 | 2002 | 81 | |
| 4 | 2004 | 60 | |
| 5 | 2006 | 57 | |
| 6 | 2012 | 56 | |
| 7 | 2022 | 49 | |
| 8 | 2006 | 44 | |
| 9 | 2014 | 43 | |
| 10 | 2008 | 28 | |
| 11 | 2008 | 27 | |
| 12 | 2016 | 24 | |
| 13 | 2005 | 20 | |
| 14 | High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how? | 2005 | 20 |
| 15 | 2015 | 19 | |
| 16 | 2020 | 19 | |
| 17 | 1997 | 18 | |
| 18 | 2015 | 18 | |
| 19 | 2009 | 17 | |
| 20 | 2019 | 17 |
About Dalibor Valík
Dalibor Valík is a scholar working on Oncology, Molecular Biology, Immunology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 73 papers that have together received 1.1k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Mass Spectrometry Techniques and Applications (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Cancer Research (212 citations), Genetics (119 citations), Oncology (300 citations), Immunology (155 citations) and Molecular Biology (474 citations). Dalibor Valík has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Jaroslav Štěrba, Bořivoj Vojtěšek, Lenka Zdražilová Dubská, Regina Demlová, Michael A. Sheard, Viera Bajčiová, Rudolf Nenutil, Rostislav Vyzula, Zdeněk Pavelka and Radka Obermannová. Their work appears in journals such as Annals of Oncology, Oncology, Frontiers in Oncology, Physiological Research and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.